Mar 19, 2026 12:57PM
Feb 25, 2026 08:59PM
Feb 25, 2026 08:59PM
Feb 25, 2026 04:01PM
Feb 25, 2026 04:01PM
Sep 16, 2025 06:51AM
Aug 14, 2025 02:07PM Guggenheim on Larimar Therapeutics (LRMR): 'remains on track to present initial OLE data in Sept 2025'
Jul 31, 2025 04:15PM
Jul 31, 2025 04:15PM
Jul 29, 2025 11:50PM
Jul 29, 2025 11:50PM
Jul 29, 2025 04:02PM
Jul 29, 2025 04:01PM
Jun 25, 2025 06:07AM Guggenheim Reiterates Buy Rating on Larimar Therapeutics (LRMR)
Dec 16, 2024 01:55PM
Feb 16, 2024 04:20PM
Feb 14, 2024 06:15AM
Feb 14, 2024 06:15AM
Feb 14, 2024 06:13AM
Feb 13, 2024 04:19PM
Feb 13, 2024 04:18PM Larimar Therapeutics Announces Proposed Underwritten Public Offering
Nov 1, 2023 04:05PM
Mar 28, 2023 04:05PM
Nov 7, 2022 04:05PM
Sep 16, 2022 01:00PM
Sep 14, 2022 07:04AM
Sep 14, 2022 07:04AM
Nov 15, 2021 07:00AM Larimar Therapeutics to Participate in the Guggenheim Virtual Neuro/Immunology Conference
May 21, 2021 09:19AM
May 21, 2021 09:18AM
Nov 13, 2020 08:00AM
Nov 13, 2020 08:00AM

22,901 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All